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SUMMARY
Animal experiments have shown that respiratory administration of pertussis
antigen induces a protective immune response. In this study pertussis antibody
in human respiratory secretions was measured and the response to aerosol and
intramuscular pertussis immunization investigated. Substantial increases in this
antibody occurred after aerosol immunization but no changes were found in serum
antibody. The reverse was observed after intramuscular immunization. Severe
side effects are frequently seen after intramuscular pertussis vaccine in adults but
not with aerosol immunization. The latter method may be of value for paediatric
medical and nursing personnel exposed to the risk of pertussis infection.
INTRODUCTION
Dow (1940) showed that mice could be immunized by nasal instillation of
B. pertussis antigens against respiratory challenge with the homologous organism.
North & Anderson (1942) suggested that the immunity obtained by this technique
was both a general (circulating) specific immunity and a local respiratory immunity
in which non-specific factors played a part. Cooper (1952) reported that intranasal
instillation of sublethal doses of live B. pertussis in mice appeared to induce a
general and local immunity to challenge but pertussis vaccine given by this route
produced only a local immunity to infection. Andersen (1952) suggested that
larger doses of pertussis vaccine given intranasally would induce general as well
as local respiratory immunity.
Immunoglobulins are known to be present in the respiratory secretions (Tomasi,
Tan, Soloman & Prendergast, 1965) and are associated with specific antibody
activity (Alford, Rossen, Butler & Kasel, 1967) which is contained almost entirely
in the IgA fraction. Most investigations into respiratory immunization have been
conducted with influenza vaccine and the results evaluated by epidemiological
studies, respiratory secretory antibody response and by live challenge procedures
(Mann et al. 1968; Waldman, Mann & Kasel, 1968; Kasel et al. 1969; Thomas,
1973). These studies have shown that specific protective antibodies can be induced
in respiratory tract secretions by local application of antigens. Holt (1972)
restated the suggestions made by North & Anderson thirty years earlier regarding
immunity to whooping cough, i.e. there exists a general immunity (involving
polymorphs and an opsonin) mobilized by the inflammatory response at the surface
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of the respiratory mucous membrane and a local prophylactic immunity involving
specific secretory IgA antibodies.
The investigations described in this paper are concerned with the variations in
antibody concentrations in respiratory secretions after aerosol and intramuscular
immunization with B. pertussis vaccine. Holt (1972) attempted to detect antibody
to B. pertussis in respiratory secretions and sera from an aerosol-immunized
Taiwan monkey, using a tissue culture adsorption-inhibition technique, and
obtained very variable results. In the investigations described in this paper a
radio-immunoassay technique was used to estimate antibody titre to B. pertussis
in respiratory secretions.
MATERIALS AND METHODS
Vaccines
The intramuscular pertussis vaccine contained 4 x 1010 organisms/ml. (Burroughs
Wellcome & Co., London). Respiratory pertussis vaccine was prepared by freeze-
drying the intramuscular vaccine and was administered by means of a metered
dose pressurized aerosol container (3 Ms Laboratories, Loughborough, England).
Respiratory secretions and sera
Respiratory secretions were obtained from eight human volunteers and examined
for protein and IgA content as previously described (Thomas, 1973). Antibody
titres in respiratory secretions were examined by passive haemagglutination
(Cruickshank, Duguid & Swain, 1965) and a radio-immunoassy technique (Restall,
Thomas & Pennant, 1973) adapted from the method described by Rosenthal,
Hayashi & Notkins (1972). Since the IgA content of the nasal secretion samples
(and hence the antibody concentrations) varied considerably from one sample to
another a standardization procedure was adopted to make the samples comparable.
mu r ii • r 1 J counts/second x 100
The following formula was used —; . Antibody titres in sera were
&
 IgA content J
assayed by the passive haemagglutination method, using the vaccine strain of
B. pertussis to coat the sensitized sheep cells.
Immunization and sampling procedures
Six adult volunteers received 3 doses of 0-5 ml. of vaccine intramuscularly at
monthly intervals. Serum and respiratory secretion samples were obtained before
immunization and 3 weeks after the last dose of vaccine. Eight adult volunteers
received one dose of aerosol vaccine inhaled via the nostrils (equivalent to 0-5 ml.
of the vaccine given intramuscularly). Serum and respiratory secretion samples
were obtained before immunization and 3 weeks after immunization.
RESULTS
Passive haemagglutination
Antibody was not detectable in any of the respiratory secretion samples by this
method (nor by slide or tube agglutination) from the two groups of volunteers.
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Table 1. Serum antibody titres for Bordetella pertussis by passive haemagglutination
method, in aerosol immunized and intramuscularly immunized volunteers
Aerosol immunization Intramuscular immunization
Volun-
teer
no.
1
2
3
4
5
6
7
8
Reciprocal
serum
Before
immuniz-
ation
4
8
4
4
8
2
4
4
i titres
A
After
immuniz-
ation
4
8
4
2
8
4
4
8
Volun-
teer
no .
9
10
11
12
13
14
Reciprocal
serum titres
A
c \Before After
immuniz- immuniz
ation ation
2 16
8 32
8 128
4 32
8 16
4 32
Table 2. Radio-immunoassay of antibody to Bordetella pertussis in respiratory
secretions from aerosol immunized and intramuscularly immunized volunteers
Before immunization After immunization
Volunteer
no.
1 aer*
2
3
4
5
6
7
8
9i.m.f
10
11
12
13
14
IgA
(/ig./ml.)
59-3
50-5
71-3
39-7
25-0
28-0
14-1
18-2
1 1 0
11-0
3 9 0
49-0
1 2 0
27-0
c/s
338
265
112
225
236
96
117
145
35
83
780
170
25
91
c/sx 100
IgA
570
525
157
567
944
343
830
797
318
754
2000
346
208
337
IgA
(/tg./ml.)
28-0
28-0
11-7
15-5
20-7
8-8
30-0
20-7
20-7
15-5
11-7
31-5
44-2
20-7
c/s
307
213
55
208
266
87
258
280
c/s x 100
I g A
1096
760
470
1342
1285
989
860
1353
Difference
+ 526
+ 235
+ 313
+ 775
+ 341
+ 646
+ 30
+ 556
Average difference + 428
74
134
259
96
84
69
Ave
357
864
2214
305
190
333
+ 39
+ 110
+ 214
- 4 1
- 1 8
- 4
;rage difference + 50
* Aer = aerosol immunized. f i-m- = intramuscularly immunized,
c/s = counts/second.
Serum antibody to B. pertussis (Table 1) was present in all the samples from both
groups. No significant changes were seen in the aerosol post-immunization serum
titres while five of the six intramuscular post-immunization titres showed four-
fold or greater increases.
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Radio-immunoassay
B. pertussis antibody was present in all the respiratory secretion samples from
both groups (Table 2). Significant changes were evident only in the aerosol post-
immunization samples.
DISCUSSION
Serum antibody titres to B. pertussis are frequently relatively low in adults
(Kendrick et al. 1969; Abbott, Preston & Mackay, 1971). Even after several intra-
muscular injections antibody titres do not rise remarkably (Abbott et al. 1971).
The titres for the intramuscularly immunized volunteers (Table 1) are similar to
those described by other workers. It is thus not surprising that increases in serum
antibody titres were not recorded after aerosol immunization with only a third
of the quantity of antigen given to the intramuscularly immunized group.
Detection of antibody to B. pertussis in respiratory secretions required the
sensitivity of the radio-immunoassay technique. The results in Table 2 show a
reversal of the situation compared with serum antibody. Substantial increases in
antibody titre were observed in all of the samples from the aerosol-immunized
volunteers, while the intramuscularly immunized group showed only small in-
creases in titre in half of the samples. The numbers involved however are small and
similar investigations in larger groups are obviously desirable to verify these
observations.
Holt (1972) suggested that the antibody present in respiratory secretions acts
by inhibiting adhesion of the organism to the cilia of the mucous membrane while
the serum antibody has a bactericidal effect exerted when inflammatory changes
in the mucous membrane permit transudation of serum proteins. Under these
circumstances aerosol immunization (with the dose of antigen given in this
investigation) appears to induce only the prophylactic protective mechanism since
serum antibody concentrations were unchanged. Larger doses, up to the level of
the intramuscular regimen, may however influence serum antibody.
Aerosol immunization against whooping cough cannot at this stage be recom-
mended for use in infants but it may have a place in the protection of adults,
especially those exposed to infection such as doctors and nursing staff concerned
with paediatric infectious diseases. Outbreaks of whooping cough in adults are
known to occur (Editorial, 1968). Intramuscular immunization of adults is often
associated with severe side effects (as was observed during the course of this
investigation). Aerosol administration of the B. pertussis antigens was not ac-
companied by any side effects in the eight volunteers (nor by the author who
received four doses by this route). For adults aerosol immunization would be
a much preferred method of protection.
I wish to thank Mr S. W. F. Restall and Mr J. H. Pennant for technical assist-
ance with these investigations and 3 Ms Laboratories, Loughborough, England
for their assistance in preparing the B. pertussis aerosol vaccine.
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